WO2003077643A3 - Verfahren zum erhöhen des ölgehaltes in pflanzen indem die menge eines oder mehrerer speicherproteine verringert wird - Google Patents

Verfahren zum erhöhen des ölgehaltes in pflanzen indem die menge eines oder mehrerer speicherproteine verringert wird Download PDF

Info

Publication number
WO2003077643A3
WO2003077643A3 PCT/EP2003/002733 EP0302733W WO03077643A3 WO 2003077643 A3 WO2003077643 A3 WO 2003077643A3 EP 0302733 W EP0302733 W EP 0302733W WO 03077643 A3 WO03077643 A3 WO 03077643A3
Authority
WO
WIPO (PCT)
Prior art keywords
content
plants
increasing
reducing
storage proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2003/002733
Other languages
English (en)
French (fr)
Other versions
WO2003077643A2 (de
Inventor
Joerg Bauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Plant Science GmbH
Original Assignee
BASF Plant Science GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF Plant Science GmbH filed Critical BASF Plant Science GmbH
Priority to AU2003209737A priority Critical patent/AU2003209737A1/en
Publication of WO2003077643A2 publication Critical patent/WO2003077643A2/de
Publication of WO2003077643A3 publication Critical patent/WO2003077643A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/52—Juglandaceae (Walnut family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Edible Oils And Fats (AREA)

Abstract

Die Erfindung betrifft Verfahren zum Erhöhen des Ölgehaltes in Pflanzen durch Verminderung eines oder mehrerer Speicherproteine. Die Erfindung betrifft ferner die Verwendung von Pflanzen mit einer verminderten Speicherproteingehalt zur Herstellung von Nahrungs-, Futtermitteln, Saatgut, Pharmazeutika oder Feinchemikalien, insbesondere zur Herstellung von Ölen.
PCT/EP2003/002733 2002-03-20 2003-03-17 Verfahren zum erhöhen des ölgehaltes in pflanzen indem die menge eines oder mehrerer speicherproteine verringert wird Ceased WO2003077643A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003209737A AU2003209737A1 (en) 2002-03-20 2003-03-17 Methods for increasing the oil content in plants by reducing the content of one or more storage proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10212893.6 2002-03-20
DE2002112893 DE10212893A1 (de) 2002-03-20 2002-03-20 Verfahren zum Erhöhen des Ölgehaltes in Pflanzen

Publications (2)

Publication Number Publication Date
WO2003077643A2 WO2003077643A2 (de) 2003-09-25
WO2003077643A3 true WO2003077643A3 (de) 2004-01-08

Family

ID=27815874

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/002733 Ceased WO2003077643A2 (de) 2002-03-20 2003-03-17 Verfahren zum erhöhen des ölgehaltes in pflanzen indem die menge eines oder mehrerer speicherproteine verringert wird

Country Status (3)

Country Link
AU (1) AU2003209737A1 (de)
DE (1) DE10212893A1 (de)
WO (1) WO2003077643A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR047598A1 (es) * 2004-02-10 2006-01-25 Monsanto Technology Llc Semilla de maiz transgenica con mayor contenido de aminoacidos
US7855323B2 (en) * 2004-02-10 2010-12-21 Monsanto Technology Llc Recombinant DNA for gene suppression
CN101128588A (zh) 2004-08-11 2008-02-20 孟山都技术有限公司 转基因玉米种子中增强的玉米醇溶蛋白减少
WO2008027592A2 (en) * 2006-08-31 2008-03-06 Monsanto Technology, Llc Phased small rnas
JP6034053B2 (ja) * 2012-04-26 2016-11-30 トヨタ自動車株式会社 植物の種子総量の増産方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0787801A2 (de) * 1996-02-01 1997-08-06 Mitsubishi Corporation Verfahren zur Steigerung des Speicherlipidgehaltes der Pflanzensamen
WO1998026064A2 (en) * 1996-12-09 1998-06-18 Dekalb Genetics Corporation Method for altering the nutritional content of plant seed
WO1999053050A1 (en) * 1998-04-08 1999-10-21 Commonwealth Scientific And Industrial Research Organisation Methods and means for obtaining modified phenotypes
WO2002000904A2 (en) * 2000-06-23 2002-01-03 E. I. Du Pont De Nemours And Company Recombinant constructs and their use in reducing gene expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0620281A3 (de) * 1993-03-31 1995-05-03 Mitsubishi Corp Wertsaat-produzierende Ölsaaten mit veränderter Amino und Fettsäure-Kompositionen.
US6506559B1 (en) * 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0787801A2 (de) * 1996-02-01 1997-08-06 Mitsubishi Corporation Verfahren zur Steigerung des Speicherlipidgehaltes der Pflanzensamen
WO1998026064A2 (en) * 1996-12-09 1998-06-18 Dekalb Genetics Corporation Method for altering the nutritional content of plant seed
WO1999053050A1 (en) * 1998-04-08 1999-10-21 Commonwealth Scientific And Industrial Research Organisation Methods and means for obtaining modified phenotypes
WO2002000904A2 (en) * 2000-06-23 2002-01-03 E. I. Du Pont De Nemours And Company Recombinant constructs and their use in reducing gene expression

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HAMMOND S M ET AL: "POST-TRANSCRIPTIONAL GENE SILENCING BY DOUBLE-STRANDED RNA", NATURE REVIEWS GENETICS, MACMILLAN MAGAZINES, GB, vol. 2, no. 2, February 2001 (2001-02-01), pages 110 - 119, XP001146153 *
MATZKE M A ET AL: "Transgene silencing by the host genome defense: Implications for the evolution of epigenetic control mechanisms in plants and vertebrates", PLANT MOLECULAR BIOLOGY, NIJHOFF PUBLISHERS, DORDRECHT, NL, vol. 43, no. 2-3, June 2000 (2000-06-01), pages 401 - 415, XP002189062, ISSN: 0167-4412 *
WESLEY S VARSHA ET AL: "Construct design for efficient, effective and high-throughput gene silencing in plants", PLANT JOURNAL, BLACKWELL SCIENTIFIC PUBLICATIONS, OXFORD, GB, vol. 27, no. 6, September 2001 (2001-09-01), pages 581 - 590, XP002187670, ISSN: 0960-7412 *

Also Published As

Publication number Publication date
DE10212893A9 (de) 2004-09-09
WO2003077643A2 (de) 2003-09-25
AU2003209737A8 (en) 2003-09-29
DE10212893A1 (de) 2003-10-16
AU2003209737A1 (en) 2003-09-29

Similar Documents

Publication Publication Date Title
EP1795257A3 (de) Verfahren zur Herstellung einer essbaren Dispersion enthaltend Öl und Struktubildner
HUP0400375A3 (en) Composition containing fat oil and onion extract, the production and use thereof
EP1277473A4 (de) Hilfsmittel
ZA200409321B (en) Oil soluble compositions.
EP2415760A3 (de) CCR-9-Antagonisten
ZA200208260B (en) Process for converting waxy feeds into low haze heavy base oil.
AU2003244023A1 (en) Lubricating oil additive, lubricating oil composition containing the same, and process for producing the same
WO2005037198A3 (en) Preparation of 1,7-disubstituted azabenzimidazoles as kinase inhibitors
WO2006015159A3 (en) Potassium channel inhibitors
WO2004069152A3 (en) Δ4,5 glycuronidase and uses thereof
WO2004107879A3 (en) High protein and high fiber food products
WO2007066232A3 (en) Salts of fatty acids and methods of making and using thereof
WO2005059155A3 (de) Verfahren zur isolierung von methionin aus einem fermentationsüberstand
AU2002358051A1 (en) Method for separating xylose from lignocelluloses rich in xylan, in particular wood
WO2004015085A3 (en) Method and compositions relating to 5’-chimeric ribonucleic acids
WO2006069668A8 (de) Verfahren zur herstellung eines rohöls aus gemischen von mikroorganismen und pflanzen, das so hergestellte öl sowie die spezifischen verwendungen des so hergestellten und gegebenenfalls zusätzlich raffinierten öls
WO2005023302A3 (en) Anti-cd20 therapy of ocular disorders
WO2004031202A3 (de) Kondensierte palatinose in hydrierter form
WO2004082366A3 (en) Methods to confer enhanced floral properties to plants
AU2002234611A1 (en) Oil blends
WO2004113528A3 (en) Isoforms of elf-5a: senescence-induced elf5a; wounding-induced elf-5a; growth elf-5a; and dhs
WO2003077643A3 (de) Verfahren zum erhöhen des ölgehaltes in pflanzen indem die menge eines oder mehrerer speicherproteine verringert wird
WO2007063034A3 (de) Basismaterial für die herstellung von lebens- und futtermitteln
WO2006012594A3 (en) Modification of lignin biosynthesis
WO2005058364A3 (en) Preservative system

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP